Abstract
A polymerase chain reaction enzyme immunoassay (PCR-EIA) was developed for the semiquantification of circulating candidal DNA in disseminated candidiasis due toCandida albicans. Polymerase chain reaction was based on primers from the internal transcribed ribosomal region. Binding of the product to a streptavidin-coated microtitration plate was mediated by a biotinylated capture probe. The product was digoxigenylated during PCR; this was the tag to which antibody was bound in the subsequent EIA. The optical density (OD) endpoint was <0.1 in 15 sera from patients with no evidence of candidal infection (group 1) and in 13 of the 16 sera from colonised patients (group 2); it was >0.1 in the other three sera from group 2 blood culture-negative patients who required intravenous amphotericin B for cure. The OD was positive in 28 patients with disseminated candidiasis (group 3), defined as positive blood cultures and successful treatment with amphotericin B (n=11), positive blood culture confirmed at autopsy (n=11), or negative blood culture first proven at necropsy (n=6). In patients from whom multiple samples were available, recovery correlated with an optical density of <0.1 by day 4 in four patients and by day 13 in the rest. In the five patients with fatal outcome from whom multiple samples were available, the mean OD rose from 0.174 to 0.668. Samples seeded withCandida albicans blastoconidia demonstrated that an OD of 0.220 was equivalent to 10 cfu. Assay of the group 3 sera by a commercial antigen detection test gave a corresponding sensitivity of 60%, which rose to 67.9% when an in-house reverse passive latex agglutination test was used.
Similar content being viewed by others
References
Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, Edwards JR, Tolson J, Henderson T, Martone WJ: Secular trends in nosocomial primary bloodstream infections in the United States. American Journal of Medicine 1991, 91: Supplement 3B: 86–89.
Edwards JE Jr: Invasive Candida infections — evolution of a fungal pathogen. New England Journal of Medicine 1991,324: 1060–1062.
Verfaillie C, Weisdorf D, Haake R, Hostetter M, Ramsay NK, McGlave P:Candida infections in bone marrow transplant recipients. Bone Marrow Transplant 1991, 8: 177–184.
Hay RJ: Liposomal amphotericin B, AmBisome. Journal of Infectious Diseases 1994, 28: Supplement 1: 35–43.
de Repentigny L, Reiss E: Current trends in immunodiagnosis of candidiasis and aspergillosis. Reviews of Infectious Diseases 1984, 6: 301–312.
Matthews RC, Burnie JP, Tabaqchali S: Isolation of the immunodominant antigen from sera of patients with systemic candidiasis and characterisation of serological response toCandida albicans. Journal of Clinical Microbiology 1987, 26: 230–237.
Gentry LO, Wilkinson ID, Lea AS, Price MF: Latex agglutination test for detection ofCandida antigen in patients with disseminated disease. European Journal of Clinical Microbiology 1983, 2: 122–128.
Mitsutake K, Takashige M, Takoyoshi T, Yamamoto Y, Kakeya H, Otsubo T, Kawamura S, Hossain MA, Noda T, Hirakata Y, Kohno S: Enolase antigen, mannan antigen, Cand-Tec antigen and β-glucan in patients with candidemia. Journal of Clinical Microbiology 1996, 34: 1918–1921.
Herent P, Stynen D, Hernando F, Fruit J, Poulin D: Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidiasis. Journal of Clinical Microbiology 1992, 30: 2158–2164.
Walsh TJ, Hawthorn JW, Sobel JD, Merz WG, Sanchez V, Maret SM, Buckley HR, Pfaller MA, Schaufele R, Sliva C, Navarro E, Lecciones J, Chandrasekar P, Lee J, Pizzo PA: Detection of circulatingCandida enolase by immunoassay in patients with cancer and invasive candidiasis. New England Journal of Medicine 1991, 324: 1026–1031.
Kan VL: Polymerase chain reaction for the diagnosis of candidemia. Journal of Infectious Diseases 1993, 168: 779–783.
Crampin AC, Matthews RC: Application of the polymerase chain reaction to the diagnosis of candidosis by amplification of an HSP90 gene fragment. Journal of Medical Microbiology 1993, 39: 233–238.
Buchman TG, Roussier MD, Merz WG, Charache P: Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification ofCandida albicans by in vitro amplification of a fungus-specific gene. Surgery 1990, 108: 338–347.
Fujita S, Lasker BA, Lott TJ, Reiss E, Morrison CJ: Microtitration plate enzyme immunoassay to detect PCR-amplified DNA fromCandida species in blood. Journal of Clinical Microbiology 1995, 33: 962–967.
Golbang N, Burnie JP, Klapper PE, Bostock A, Williamson P: Sensitive and universal method for microbial DNA extraction from blood products. Journal of Clinical Pathology 1996, 49: 861–863.
Burnie JP: A reverse passive latex agglutination test for the diagnosis of invasive candidiasis. Journal of Immunological Methods 1985, 82: 267–281.
Chryssanthou E, Anderson B, Petrini B, Lofdahl S, Tollemar J: Detection ofCandida albicans in serum by polymerase chain reaction. Scandinavian Journal of Infectious Diseases 1994, 26: 479–485.
Burgener-Kairuz P, Zuber JP, Buchman TG, Bille J, Rossier M: Rapid detection and identification ofCandida albicans andTorulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-α demethylase (L1A1) gene fragment. Journal of Clinical Microbiology 1994, 32: 1902–1907.
Makimura K, Murayama SY, Yamaguchi H: Detection of a wide range of medically important fungi by the polymerase chain reaction. Journal of Medical Microbiology 1994, 40: 358–364.
Van Deventer AJM, Goessens WHF, van Belkum A, van Vliet HJA, van Etten EWM, Verburgh HA: Improved detection ofCandida albicans by PCR in blood of neutropenic mice with systemic candidiasis. Journal of Clinical Microbiology 1995, 33: 625–628.
Miyakawa Y, Mabuchi T, Kagaya K, Fukazawa Y: Isolation and characterisation of a species-specific DNA fragment for detection ofCandida albicans by polymerase chain reaction. Journal of Clinical Microbiology 1992, 30: 894–900.
Miyakawa Y, Mabuchi T, Kagaya K, Fukazawa Y: New method for detection ofCandida albicans in human blood by polymerase chain reaction. Journal of Clinical Microbiology 1993, 31: 3344–3347.
Holmes AR, Cannon RD, Shepherd MG, Jenkinson HF: Detection ofCandida albicans and other yeasts in blood by PCR. Journal of Clinical Microbiology 1994, 34: 228–231.
Hopfer RL, Walden P, Setterquist S, Highsmith WE: Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis. Journal of Medical and Veterinary Mycology 1993, 31: 65–75.
Muncan P, Wise GJ: Early identification of candiduria by polymerase chain reaction in high risk patients. Journal of Urology 1996, 156: 154–156.
Ralph ED, Hussain Z: Chronic meningitis caused byCandida albicans in a liver transplant recipient — usefulness of the polymerase chain reaction for diagnosis and for monitoring treatment. Clinical Infectious Diseases 1996, 23: 191–192.
Philips P, Dowd A, Jewesson P, Radigan G, Tweeddale MG, Clarke A, Geere I, Kelly M: Nonvalue of antigen detection immunoassay for diagnosis of candidemia. Journal of Clinical Microbiology 1990, 28: 2320–2326.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Burnie, J.P., Golbang, N. & Matthews, R.C. Semiquantitative polymerase chain reaction enzyme immunoassay for diagnosis of disseminated Candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 16, 346–350 (1997). https://doi.org/10.1007/BF01726361
Issue Date:
DOI: https://doi.org/10.1007/BF01726361